PL401469A1 - Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja - Google Patents

Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja

Info

Publication number
PL401469A1
PL401469A1 PL401469A PL40146901A PL401469A1 PL 401469 A1 PL401469 A1 PL 401469A1 PL 401469 A PL401469 A PL 401469A PL 40146901 A PL40146901 A PL 40146901A PL 401469 A1 PL401469 A1 PL 401469A1
Authority
PL
Poland
Prior art keywords
derivative
medicine
production
azabicyclic
composition
Prior art date
Application number
PL401469A
Other languages
English (en)
Other versions
PL234468B1 (pl
Inventor
Maxime Lampilas
Jozsef Aszodi
David Alan Rowlands
Claude Fromentin
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8853181&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL401469(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novexel filed Critical Novexel
Publication of PL401469A1 publication Critical patent/PL401469A1/pl
Publication of PL234468B1 publication Critical patent/PL234468B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL401469A 2000-08-01 2001-07-24 Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierająca tą pochodną kompozycja PL234468B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0010121A FR2812635B1 (fr) 2000-08-01 2000-08-01 Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR00/10121 2000-08-01
PCT/FR2001/002418 WO2002010172A1 (fr) 2000-08-01 2001-07-24 Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens

Publications (2)

Publication Number Publication Date
PL401469A1 true PL401469A1 (pl) 2013-02-04
PL234468B1 PL234468B1 (pl) 2020-02-28

Family

ID=8853181

Family Applications (2)

Application Number Title Priority Date Filing Date
PL365162A PL216028B1 (pl) 2000-08-01 2001-07-24 Pochodna azabicykliczna, jej zastosowanie jako lek oraz zawierajaca ja kompozycja
PL401469A PL234468B1 (pl) 2000-08-01 2001-07-24 Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierająca tą pochodną kompozycja

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL365162A PL216028B1 (pl) 2000-08-01 2001-07-24 Pochodna azabicykliczna, jej zastosowanie jako lek oraz zawierajaca ja kompozycja

Country Status (42)

Country Link
US (5) US7112592B2 (pl)
EP (1) EP1307457B1 (pl)
JP (2) JP4515704B2 (pl)
KR (1) KR100632906B1 (pl)
CN (1) CN1289500C (pl)
AP (1) AP1614A (pl)
AR (1) AR031716A1 (pl)
AT (1) ATE263768T1 (pl)
AU (2) AU7990501A (pl)
BG (1) BG66094B1 (pl)
BR (1) BRPI0112986B8 (pl)
CA (1) CA2417475C (pl)
CR (1) CR6895A (pl)
CZ (1) CZ294956B6 (pl)
DE (1) DE60102702T2 (pl)
DK (1) DK1307457T3 (pl)
DZ (1) DZ3397A1 (pl)
EA (1) EA004920B1 (pl)
EC (1) ECSP034460A (pl)
EE (1) EE05183B1 (pl)
ES (1) ES2220793T3 (pl)
FR (1) FR2812635B1 (pl)
HK (1) HK1060356A1 (pl)
HR (1) HRP20030034B1 (pl)
HU (1) HU226889B1 (pl)
IL (2) IL154187A0 (pl)
MA (1) MA26938A1 (pl)
ME (2) MEP17108A (pl)
MX (1) MXPA03000881A (pl)
NO (1) NO324940B1 (pl)
NZ (1) NZ523707A (pl)
OA (1) OA12347A (pl)
PL (2) PL216028B1 (pl)
PT (1) PT1307457E (pl)
RS (1) RS50214B (pl)
SI (1) SI1307457T1 (pl)
SK (1) SK287597B6 (pl)
TR (1) TR200400859T4 (pl)
TW (1) TWI292401B (pl)
UA (1) UA73791C2 (pl)
WO (1) WO2002010172A1 (pl)
ZA (1) ZA200300676B (pl)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
JP5180836B2 (ja) 2005-12-07 2013-04-10 バジリア ファルマスーチカ アーゲー モノバクタム系抗生物質とβ−ラクタマーゼ系阻害剤との有用な組み合わせ
AU2007272839B2 (en) 2006-07-13 2012-05-24 Achillion Pharmaceuticals, Inc. 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
EP2040698A4 (en) * 2006-07-14 2011-08-10 Shionogi & Co OXIM CONNECTIONS AND ITS USE
AU2007300531A1 (en) * 2006-09-27 2008-04-03 Merck Sharp & Dohme Corp. Novel inhibitors of beta-lactamase
MX2009004290A (es) * 2006-10-23 2009-07-27 Irm Llc Inhibidores de proteasas de catepsina.
US20100056497A1 (en) 2007-01-31 2010-03-04 Dainippon Sumitomo Pharma Co., Ltd Amide derivative
FR2914923B1 (fr) * 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.
JP5323063B2 (ja) * 2007-05-31 2013-10-23 塩野義製薬株式会社 オキシイミノ化合物およびその使用
FR2921060B1 (fr) * 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
CN101918407B (zh) * 2008-01-18 2014-02-26 默沙东公司 β-内酰胺酶抑制剂
ES2408159T3 (es) 2008-06-11 2013-06-18 Shionogi & Co., Ltd. Compuestos de oxicarbamoilo y su utilización
EP2135959A1 (en) 2008-06-19 2009-12-23 Novexel Use of (1R,2S,5R) 1,6-Diazabicyclo [3,2,1]octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, monosodium salt as a diagnostic reagent for detecting serine beta-lactamases
FR2936798B1 (fr) 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
WO2010126820A2 (en) * 2009-04-30 2010-11-04 Merck Sharp & Dohme Corp. Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
AU2010263641A1 (en) 2009-06-24 2012-01-19 Sumitomo Dainippon Pharma Co., Ltd. N-substituted-cyclic amino derivative
FR2951171A1 (fr) * 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
CA2822758C (en) * 2010-12-22 2018-03-20 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and process for preparing the same
US8772490B2 (en) 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
RU2610091C2 (ru) 2011-06-17 2017-02-07 Астразенека Аб (2S,5R)-5-[(бензилокси)амино]пиперидин-2-карбоксамид
HUE030311T2 (en) * 2011-08-27 2017-04-28 Wockhardt Ltd 1,6-Diazabicyclo [3.2.1] octan-7-one derivatives and their use for the treatment of bacterial infections
US9006230B2 (en) * 2011-08-30 2015-04-14 Wockhardt Ltd. 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
CA2846107C (en) * 2011-09-13 2016-06-21 Wockhardt Limited Nitrogen containing compounds and their use
US8969567B2 (en) 2011-09-13 2015-03-03 Wockhardt Ltd. Nitrogen containing compounds and their use
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
KR20140144254A (ko) 2012-03-30 2014-12-18 큐비스트 파마슈티컬즈 인코포레이티드 1,3,4-옥사디아졸 및 1,3,4-티아디아졸 β-락타마제 억제제
US8969570B2 (en) 2012-03-30 2015-03-03 Cubist Pharmaceuticals, Inc. Beta-lactamase inhibitors
CA2869051A1 (en) 2012-03-30 2013-10-03 Cubist Pharmaceuticals, Inc. Isoxazole .beta.-lactamase inhibitors
US8916709B2 (en) 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
AR090539A1 (es) * 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
BR112014029368B1 (pt) 2012-05-30 2020-10-27 Meiji Seika Pharma Co., Ltd inibidor de beta-lactamase e processo para preparar o mesmo
EP3360877B1 (en) * 2012-08-25 2021-02-17 Wockhardt Limited 1,6- diazabicyclo [3,2,1]octan- 7- one derivatives and their use in the treatment of bacterial infections
SG11201503427TA (en) 2012-11-01 2015-06-29 Kaneka Corp Process for producing optically active bicyclic urea compound
UA111925C2 (uk) 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
WO2014129459A1 (ja) 2013-02-19 2014-08-28 株式会社エーピーアイ コーポレーション Ｌ－リジン水酸化酵素およびそれを利用したヒドロキシ－ｌ－リジンの製造法およびヒドロキシ－ｌ－ピペコリン酸の製造法
BR112015021240A2 (pt) * 2013-03-08 2017-07-18 Wockhardt Ltd processo para sal de sódio de (2s, 5r)-2-carboxamido-7-oxo-6-sulfo-oxi-1,6-diaza-biciclo[3.2.1]octano
US9862718B2 (en) * 2013-03-08 2018-01-09 Wockhardt Limited Sodium salt of (2S, 5R)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1] octane-2-carboxylic acid and its preparation
EP2970338A1 (en) 2013-03-14 2016-01-20 Merck Sharp & Dohme Corp. Crystalline form of a beta-lactamase inhibitor
CA2911544A1 (en) 2013-06-10 2014-12-18 Merck Sharp & Dohme Corp. Preparation of tert-butyl 4-((1r,2s,5r)-6-(benzyloxy)-7-0x0-1,6-diazabicycl0[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate
CN107501264A (zh) 2013-09-24 2017-12-22 明治制果药业株式会社 二氮杂二环辛烷衍生物的制备方法
US9120796B2 (en) 2013-10-02 2015-09-01 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
AR097971A1 (es) 2013-10-08 2016-04-20 Meiji Seika Pharma Co Ltd Formas cristalinas de derivado de diazabiciclooctano y proceso de producción de ellas
EP3055311B1 (en) 2013-10-11 2017-08-09 Wockhardt Limited Nitrogen containing compounds and their use
EP3096754B1 (en) 2014-01-22 2018-08-29 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors
EP3139918B1 (en) 2014-05-09 2019-12-25 Merck Sharp & Dohme Corp. Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors
CN107108624B (zh) * 2014-11-17 2020-01-07 恩塔西斯治疗有限公司 用于治疗耐药性细菌感染的组合疗法
US10053460B2 (en) 2014-12-02 2018-08-21 Merck Sharp & Dohme Corp. Process for the preparation of tert-butyl 4-((2S ,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate and analogs thereof
CN107001366B (zh) 2014-12-05 2020-08-28 明治制果药业株式会社 二氮杂二环辛烷衍生物的结晶以及稳定的冻干制剂的制备方法
US10667737B2 (en) 2015-03-23 2020-06-02 International Business Machines Corporation Monitoring a person for indications of a brain injury
EP3091018A1 (en) * 2015-05-07 2016-11-09 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
TWI754613B (zh) * 2015-05-07 2022-02-11 法商木塔比利斯公司 雜環化合物及其用於預防或治療細菌感染之用途
WO2016206101A1 (en) 2015-06-26 2016-12-29 Merck Sharp & Dohme Corp. Metallo-beta-lactamase inhibitors
WO2017002089A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002086A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002087A1 (en) 2015-07-02 2017-01-05 Wockhardtlimited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
WO2017002083A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections
AU2016307256B2 (en) 2015-08-10 2020-11-19 Sandoz Ag Form C of avibactam sodium
WO2017037607A1 (en) 2015-09-01 2017-03-09 Wockhardt Limited (aminomethylidene)amino-substituted (2s,5r)-6-(sulfonyl)-7-oxo-1,6-diazabicyclo[3.2.1 ]octane-2-carboxamide derivatives with antibacterial activity
JP2018515481A (ja) 2015-09-16 2018-06-14 シュアンチュー ファーマ カンパニー，リミティド β−ラクタマーゼ阻害剤とその利用
AU2016332964A1 (en) 2015-10-02 2018-04-12 Legochem Biosciences, Inc. Compositions and methods for inhibiting beta-lactamase
JP6947634B2 (ja) 2015-10-02 2021-10-13 株式会社エーピーアイ コーポレーション ヒドロキシ−ｌ−ピペコリン酸の製造方法
WO2017081615A1 (en) 2015-11-09 2017-05-18 Wockhardt Limited 7-oxo -6-(sulfooxy)- 1,6-diazabicyclo [3.2.1] octane containing compounds and their use in treatment of bacterial infections
CN106749242B (zh) * 2015-11-23 2021-04-02 上海医药工业研究院 阿维巴坦中间体的制备方法
WO2017136254A1 (en) 2016-02-04 2017-08-10 Merck Sharp & Dohme Corp. Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
CN105753867B (zh) * 2016-03-24 2018-03-27 齐鲁制药有限公司 一种改进的阿维巴坦钠中间体化合物的制备方法
EP3156400B1 (en) 2016-05-27 2019-05-15 Valoralia I Más D, SL Dihydrooxadiazine compounds for treating infections and cancer
CN106279163A (zh) * 2016-08-12 2017-01-04 上海龙翔生物医药开发有限公司 一种合成阿维巴坦及其中间体光学异构体的方法
CN109641901B (zh) * 2016-08-26 2022-12-09 桑多斯股份公司 阿维巴坦游离酸
MX2021010077A (es) 2016-09-16 2022-05-23 Entasis Therapeutics Ltd Compuestos inhibidores de beta-lactamasa.
JOP20190061A1 (ar) 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
EP3301094A1 (en) * 2016-09-30 2018-04-04 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
CN106699756B (zh) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 β内酰胺酶抑制剂阿维巴坦的合成方法
WO2018141991A1 (en) * 2017-02-06 2018-08-09 Mutabilis Novel heterocyclic compounds and their use in preventing or treating bacterial infections
CN110709081B (zh) 2017-05-08 2023-09-22 恩塔西斯治疗公司 用于治疗细菌感染的化合物及方法
US10085999B1 (en) 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
WO2018234962A1 (en) 2017-06-20 2018-12-27 Wockhardt Limited PROCESS FOR O-SULFONATION OF 1,6-DIAZABICYCLO [3.2.1] OCTANE COMPOUNDS
WO2019018186A1 (en) 2017-07-17 2019-01-24 Merck Sharp & Dohme Corp. METALLO-BETA-LACTAMASE INHIBITORS AND METHODS OF USE
CN111448182A (zh) 2017-10-02 2020-07-24 阿里萨制药有限公司 氨曲南衍生物及其用途
CN109678856B (zh) * 2017-10-18 2020-09-25 新发药业有限公司 一种阿维巴坦中间体的制备方法
JP7289836B2 (ja) 2017-11-23 2023-06-12 エフ． ホフマン－ラ ロシュ アーゲー プロリンヒドロキシラーゼ、ならびにそれに伴う使用、方法および生成物
CN109956941B (zh) * 2017-12-25 2020-08-04 新发药业有限公司 一种阿维巴坦的简便制备方法
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CA3114618C (en) 2018-10-01 2023-09-05 Arixa Pharmaceuticals, Inc. Derivatives of relebactam and uses thereof
CN111072660B (zh) * 2018-10-22 2021-05-18 新发药业有限公司 一种瑞来巴坦的简便制备方法
KR20210137159A (ko) 2019-03-12 2021-11-17 아릭사 파마슈티컬스 인코포레이티드 아비박탐 유도체의 결정형
US11565999B2 (en) 2019-04-25 2023-01-31 Arixa Pharmaceuticals, Inc. Methods of synthesizing aztreonam derivatives
CN110078728B (zh) * 2019-05-23 2020-10-23 江西富祥药业股份有限公司 一种阿维巴坦中间体、制备方法及其应用
WO2021106864A1 (en) * 2019-11-25 2021-06-03 Eisai R&D Management Co., Ltd. Process for the preparation of producing pyrazolo[1,5-a] pyrimidine derivatives
US11814385B2 (en) 2021-06-25 2023-11-14 University Of South Florida Small molecule inhibitors targeting Clostridioides difficile sporulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4939678B1 (pl) * 1968-05-06 1974-10-28
US4024147A (en) * 1972-06-30 1977-05-17 John Wyeth & Brother Limited Heterocyclic compounds
US4049821A (en) * 1976-05-12 1977-09-20 A. H. Robins Company, Inc. Method of treating allergy
EP0260057A3 (en) * 1986-09-02 1989-02-01 The University Of Melbourne 2-oxo-4-carboxy-pyrimidines
JPS63119471A (ja) * 1986-09-02 1988-05-24 ザ・ユニバーシテイ・オブ・メルボルン ２−オキソ−４−カルボキシ−ピリミジン
CZ282567B6 (cs) * 1993-12-29 1997-08-13 Pfizer Inc. Diazabicyklické sloučeniny a farmaceutické prostředky na jejich bázi
TW358097B (en) * 1996-05-24 1999-05-11 Hoffmann La Roche Beta-lactams and their process and pharmaceutical compositions
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
ES2224354T3 (es) * 1997-02-10 2005-03-01 Pfizer Products Inc. Piridinas 2-amino-6-(4-fenoxi-2-sustituido)sustituidas.
US6060585A (en) * 1997-03-04 2000-05-09 Wisconsin Alumni Research Foundation β-polypeptide foldamers of well-defined secondary structure
KR100207096B1 (ko) * 1997-07-08 1999-07-15 이명환 시사프라이드의 제조 방법
DE69906059D1 (de) * 1998-04-20 2003-04-24 Fujisawa Pharmaceutical Co Anthranilsäurederivate als inhibitoren der c-gmp-phosphodiesterase
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
FR2784682B1 (fr) * 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
US6635657B1 (en) * 1998-12-23 2003-10-21 Eli Lilly And Company Aromatic amides
ID29979A (id) * 1999-01-02 2001-10-25 Aventis Pharma Gmbh Turunan asam malonat baru, proses pembuatannya, penggunaannya dan komposisi sediaan farmasi yang mengandung bahan tersebut (penghambatan aktivitas faktor xa)
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Also Published As

Publication number Publication date
CZ294956B6 (cs) 2005-04-13
FR2812635B1 (fr) 2002-10-11
RS50214B (sr) 2009-07-15
JP4515704B2 (ja) 2010-08-04
NO20030494D0 (no) 2003-01-31
EE05183B1 (et) 2009-06-15
BR0112986B1 (pt) 2014-04-01
KR100632906B1 (ko) 2006-10-13
NO20030494L (no) 2003-03-28
EP1307457A1 (fr) 2003-05-07
SI1307457T1 (en) 2004-08-31
ZA200300676B (en) 2004-05-10
CR6895A (es) 2007-07-12
HRP20030034A2 (en) 2004-02-29
ATE263768T1 (de) 2004-04-15
US20060046995A1 (en) 2006-03-02
MXPA03000881A (es) 2003-06-06
IL154187A0 (en) 2003-07-31
NZ523707A (en) 2005-02-25
UA73791C2 (uk) 2005-09-15
HUP0302943A2 (hu) 2003-12-29
HK1060356A1 (en) 2004-08-06
PL216028B1 (pl) 2014-02-28
BG66094B1 (bg) 2011-04-29
TWI292401B (en) 2008-01-11
HRP20030034B1 (en) 2011-03-31
DK1307457T3 (da) 2004-08-09
CZ2003223A3 (cs) 2003-08-13
PL234468B1 (pl) 2020-02-28
CA2417475C (en) 2010-04-20
DE60102702D1 (de) 2004-05-13
CN1289500C (zh) 2006-12-13
BG107497A (bg) 2003-09-30
ES2220793T3 (es) 2004-12-16
US7732610B2 (en) 2010-06-08
DZ3397A1 (fr) 2002-02-07
EA004920B1 (ru) 2004-10-28
US20030199541A1 (en) 2003-10-23
MEP17108A (en) 2010-06-10
ECSP034460A (es) 2003-03-10
EP1307457B1 (fr) 2004-04-07
DE60102702T2 (de) 2005-04-07
AU2001279905B2 (en) 2005-12-08
HU226889B1 (en) 2010-01-28
AP2003002726A0 (en) 2003-06-30
US20110021772A1 (en) 2011-01-27
US7112592B2 (en) 2006-09-26
PT1307457E (pt) 2004-08-31
US20110213147A1 (en) 2011-09-01
OA12347A (fr) 2006-05-15
US20060189652A1 (en) 2006-08-24
SK1052003A3 (en) 2003-11-04
AU7990501A (en) 2002-02-13
IL154187A (en) 2009-02-11
WO2002010172A1 (fr) 2002-02-07
US8178554B2 (en) 2012-05-15
CN1468242A (zh) 2004-01-14
HUP0302943A3 (en) 2007-08-28
US7638529B2 (en) 2009-12-29
MA26938A1 (fr) 2004-12-20
FR2812635A1 (fr) 2002-02-08
KR20030019642A (ko) 2003-03-06
JP2010138206A (ja) 2010-06-24
CA2417475A1 (fr) 2002-02-07
BRPI0112986B8 (pt) 2021-05-25
AR031716A1 (es) 2003-10-01
BR0112986A (pt) 2003-07-08
EE200300046A (et) 2004-10-15
PL365162A1 (pl) 2004-12-27
EA200300211A1 (ru) 2003-06-26
TR200400859T4 (tr) 2004-06-21
SK287597B6 (sk) 2011-03-04
AP1614A (en) 2006-05-21
NO324940B1 (no) 2008-01-07
ME00060B (me) 2010-06-10
YU6303A (sh) 2006-03-03
JP2004505088A (ja) 2004-02-19

Similar Documents

Publication Publication Date Title
PL401469A1 (pl) Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja
EE200300151A (et) Ravimitena kasutatavad antikolinergikumid ning meetodid nende valmistamiseks
DE60134371D1 (de) Spiralkontaktor und dessen Herstellungsmethode
HUP0400333A3 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
ATE431412T1 (de) Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
DE60121878D1 (de) Mikroaktor und dessen Herstellungsverfahren
EE05149B1 (et) Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis
DE60225385D1 (de) Autentisches Document und dessen Herstellungsverfahren
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
DK1339292T3 (da) Sammensætning og fremgangsmåde
EE200200328A (et) Multši kompositsioon ja meetod
DE60023103D1 (de) Lüfter und dessen Herstellungverfahren
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
NO20031701D0 (no) Fremgangsmåte og mellomprodukter i fremstilling av 7- substituerte antiöstrogener
DE60036249D1 (de) Feldeffekttransistor und dessen Herstellungsverfahren
NO20032403L (no) SiAION-holdig ytterbium og fremgangsmåte for fremstilling derav
DE50214244D1 (de) Klauenpolläufer und dessen herstellverfahren
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DE50115516D1 (de) Alkalimetallfluorzinkat und seine herstellung
DE60120251D1 (de) Supraleitender Draht und dessen Herstellungsverfahren
FI20000194A0 (fi) Menetelmä kaupankäynnissä
NO20031108L (no) Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet
DE60037236D1 (de) Wechselstromgenerator und dessen Herstellungsverfahren